On track for August 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for ...

An Iowa stem cell company must pay $2.5 million in reimbursements and penalties for falsely advertising unapproved therapies, ...

Tecentriq SC, launched in India by the pharma giant Roche, is subcutaneous. This means it is injected directly under the skin ...

Spurred by the discoveries of human pluripotent stem cell culture by James Thomson in the 1990s and the induction of pluripotency from adult cells by Shinya Yamanaka in the 2000s, therapeutics derived ...

Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult ...

The bone metastasis in solid tumors market is expanding due to rising incidences of metastasizing solid tumors like breast, prostate, lung cancer, and renal cell carcinoma. This growth is fueled by ...

Lucknow: The Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI) has successfully performed Uttar Pradesh’s first haploidentical haematopoietic stem cell transplantation (HSCT) for a ...

In Bangkok‘s “Green Lung,” Lumphini Park, the humid air smells of damp earth and jasmine—a sharp contrast to clinical ...

Total revenue of $64.9 million in 1Q26, a 224% year-over-year increase - - Revuforj® (revumenib) net revenue of $48.9 million in 1Q26, highlighting leadership in menin inhibition and increasing uptake ...

Several ASX names are now edging into high-stakes territory, with late-stage Phase III trials underway in 2026. ... Read More The post ASX biotechs face final hurdle as Phase III catalysts loom ...

The Trump administration seems determined to reduce scientific testing on animals. Just how serious is it about its new pet ...

Immunotherapy is a class of medical treatments that harness, enhance, or redirect the body's immune system to fight disease. In its most prominent application – cancer treatment – immunotherapy works ...